Abstract: An emulsion comprising a continuous aqueous phase and a dispersed fatty phase in the form of drops, or conversely, wherein the drops comprise a shell formed of at least one anionic polymer comprising at least one carboxylic acid function and at least one cationic polymer comprising at least two amine functional groups, wherein the quantity of amine functional groups provided by the cationic polymer in the fatty phase is between 0.2 ?mol and 10.5 ?mol per gram of fatty phase.
Abstract: A hair treatment composition comprising (a) from 0.01 to 10 wt % of surfactant in a solvent, by weight of the total composition, and (b) a mixture of amino acids, wherein the mixture of amino acids comprises glutamic acid, alanine and proline gives damage repair benefits to chemically damaged hair.
Type:
Grant
Filed:
September 22, 2017
Date of Patent:
March 1, 2022
Assignee:
Conopco, Inc.
Inventors:
Benjamin Jesukumar Rajapandian, Stephen Robert Ricketts, Glyn Roberts
Abstract: A wound sealing powder, method of making a wound sealing powder, and method of using a wound sealing powder to reduce blood flow from a wound are provided. Specifically, the wound sealing powder utilizes a particulate powder material of an effective amount of an insoluble cation exchange material wherein the majority of the particles in the powder have particle sizes of less than approximately 48 microns.
Type:
Grant
Filed:
February 13, 2019
Date of Patent:
February 8, 2022
Assignee:
Biolife, L.L.C.
Inventors:
Kurt Vadelund, Talmadge Kelly Keene, Mark Travi
Abstract: The present disclosure relates generally to compositions and methods for improving gastrointestinal absorption function and correct deficiencies by preserving intestinal epithelial absorptive function. In particular, the compositions and methods for useful for improving gastrointestinal absorption of electrolytes.
Abstract: A powder preparation for nasal administration containing a particulate of steroid hormones having an average particle size of 50 to 300 ?m as an active ingredient is prepared.
Abstract: A process for preparing a potent plant based active, the process includes creating a plant salt, a plant tincture, and a plant essential oil and adding the salt either alone or with the essential oil and/or tincture to a cosmetic product as an active ingredient.
Abstract: A composition comprising at least one TCA or SSRI useful in a method for preventing or treating a skin disorder such as radiation dermatitis, and method of preventing, ameliorating, or treating the skin disorder by administering an effective amount of the TCA, e.g., amitriptyline or the SSRI, e.g., sertraline.
Abstract: This invention provides a material that is capable of preparing an external composition that achieves high smoothness and low roughness and that reflects near-infrared rays. Specifically, a granular composite comprising keratin and hexagonal plate-shaped zinc oxide particles is provided.
Abstract: Provided are pharmaceutical compositions useful for the treatment and/or prevention of a disorder, such as addiction. For example, pharmaceutical compositions are provided that comprise a first active pharmaceutical component (e.g., metyrapone) and a second active pharmaceutical component (e.g., oxazepam). The compositions may be constructed in such a manner as to limit the physical contact between the first and second active pharmaceutical components, thus preventing any degradation of the active pharmaceutical components resulting form interaction between the two components. The compositions may include at least one pharmaceutically acceptable excipient. Also provided are methods of making the compositions as well as kits containing materials to provide the compositions.
Type:
Grant
Filed:
March 12, 2018
Date of Patent:
November 23, 2021
Assignee:
Embera NeuroTherapeutics, Inc.
Inventors:
Julie Straub, Muralikrishna Duvvuri, Parag M. Ved, Bruce Rehlaender, Jay Breaux, Winston A. Vadino, Kripanath Borah, Carol Gloff
Abstract: Provided are healthcare compositions comprising a superhydrophilic amphiphilic copolymer, a micellar thickener, and a cosmetically-acceptable or pharmaceutically-acceptable carrier. Also, provided are methods of cleansing or treating a mammal by applying healthcare compositions of the present inventions to the mammalian body.
Type:
Grant
Filed:
October 7, 2009
Date of Patent:
November 16, 2021
Assignee:
Johnson & Johnson Consumer Inc.
Inventors:
Michael J. Fevola, Frank C. Sun, Joseph J. LiBrizzi, Joseph B. Gardner, Russel M. Walters
Abstract: The present invention provides formulations for oral administration of GLP-1 peptide analogs, methods of making such formulations, and methods of treatment using such formulations.
Type:
Grant
Filed:
October 30, 2018
Date of Patent:
November 16, 2021
Assignee:
MedImmune Limited
Inventors:
Sergei Pechenov, Puneet Tyagi, Janardhanan Anand Subramony
Abstract: A composition comprising at least one TCA useful in a method for treating an anorectal disorder, a rectal device and method of treating the anorectal disorder by anorectally administering an effective amount of the TCA, e.g. amitriptyline.
Abstract: There is provided low-substituted hydroxypropyl cellulose (L-HPC) having good bindability, anti-capping performance and disintegratability. More specifically, there are provided L-HPC having a hydroxypropoxy group content of 5 to 16% by mass and a volume fraction of long fibrous particles of more than 50.0% relative to all of L-HPC particles which are classified, on a basis of dynamic image analysis, into fine particles, spherical particles, the long fibrous particles and short fibrous particles; and a solid preparation containing the L-HPC.
Abstract: A water-based liquid cosmetic containing diethylhexyl sodium sulfosuccinate, an inorganic coloring pigment, a water-soluble dispersant, and a film-forming polymer emulsion, wherein a content of diethylhexyl sodium sulfosuccinate is 0.01 to 1 mass % and a content of the inorganic coloring pigment is 3 to 20 mass %, based on a total amount of the cosmetic, and wherein the inorganic coloring pigment contains carbon black.
Abstract: A controlled release pharmaceutical formulation is provided, comprising cyclosporine-loaded microparticles of a bioresorbable polymer comprising poly(D,L-lactide), wherein the mean diameter of the microparticles is in the range 20 ?m to 40 ?m. Also provided are medical uses of the pharmaceutical formulation, in particular in the treatment of uveitis, a process for production of the pharmaceutical formulation and injectable dosage forms, including those formulated for intravitreal injection.
Type:
Grant
Filed:
December 16, 2016
Date of Patent:
October 26, 2021
Assignee:
MIDATECH PHARMA (WALES) LIMITED
Inventors:
Paul Seaman, Katharine Bamsey, Nigel Thomas, Dewi Paice
Abstract: Disclosed are methods of grafting monomeric and polymeric materials on keratin-containing material to provide a covalent coating on keratin-containing material. A mixture comprising a reducing agent is applied to the keratin-containing material sample. The keratin-containing material sample then comprises a plurality of free thiol groups. A monomer is applied to the keratin-containing material sample. The free thiol groups react with the monomer to form a plurality of covalent bonds between the free thiol groups and the monomers. The reducing agent and the monomer can be applied separately, semi-simultaneously, or simultaneously. The disclosed methods can be carried out with or without catalyst. The disclosed methods can be carried out with or without an additive.
Type:
Grant
Filed:
November 16, 2018
Date of Patent:
October 19, 2021
Assignee:
Living Proof, Inc.
Inventors:
Soo-Young Kang, Zhaoxia Ji, Sara A. Johnson, Dinara A. Villanueva, Jeremiah A. Johnson, Xu Qin
Abstract: A hair fixative composition includes at least one carboxylated starch ester based polyglucose polymer, an alcohol based solvent system, and a cosmetically acceptable additive, wherein the polyglucose polymer is soluble in the alcohol based solvent system. The polyglucose polymer is obtained by reacting at least one starch ester with at least one anhydride.
Abstract: A dry consumable preparation and related methods are disclosed. The preparation has a bulking agent, and a cannabinoid and/or a cannabinoid extract containing one or more cannabinoids plated onto the bulking agent. The preparation also has an effervescence agent. The effervescence agent has sodium bicarbonate, potassium bicarbonate, and at least one acid, the at least one acid having at least one of citric acid, tartaric acid, or malic acid. The effervescence agent further has a ratio of sodium bicarbonate to potassium bicarbonate to the acid(s) that creates a chemical pH buffering system at a targeted pH range when the dry consumable preparation is added to a targeted amount of water.
Abstract: Disclosed are conjugates, compositions, and methods that include or use one or more gold(III) porphyrin complexes. Preferred conjugates are gold(III) porphyrin-poly(ethylene glycol) (PEG) conjugates. Preferred compositions and methods include or use such gold(III) porphyrin-PEG conjugates. Disclosed is a method for treatment of cancer comprising administering to a human in need of such treatment a composition containing a therapeutically effective amount of gold(III) porphyrin-poly(ethylene glycol) (PEG) conjugates. The gold(III) porphyrin-PEG conjugates can be in the form of nanostructures formed by self-assembly of the gold(III) porphyrin-PEG conjugates; or nanocomposites formed by encapsulation of other therapeutic agents by the nanostructures of gold(III) porphyrin-PEG conjugates.
Abstract: Provided is a method of encapsulation, the method including: providing a first mixture; applying heat to the first mixture until the first mixture reaches a first temperature; providing a second mixture; applying heat to the second mixture until the second mixture reaches a second temperature; mixing the first mixture with the second mixture to obtain a third mixture; providing a fourth mixture; applying heat to the fourth mixture until the fourth mixture reaches a third temperature; mixing the third mixture with the fourth mixture to obtain a fifth mixture.